Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Gespeichert in:
Veröffentlicht in: | Arthritis research & therapy 2014-09, Vol.16 (5), Article 427 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | |
container_title | Arthritis research & therapy |
container_volume | 16 |
creator | Nagai, Toshihiro Sato, Masato Kobayashi, Miyuki Yokoyama, Munetaka Tani, Yoshiki Mochida, Joji |
description | |
doi_str_mv | 10.1186/s13075-014-0427-y |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4189677</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4189677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c324y-30167fcc8b6c0f7f214ee2f550258343b0e54a3bbf6477318b50bb3cfd98df2d3</originalsourceid><addsrcrecordid>eNpVkMtKAzEUhoMotlYfwN08QKO5TqYbQUu9QMGNLlyFJJN0ItNJSdLK-PROrYjCgXPgP_-3-AC4xOgK46q8TpgiwSHCDCJGBOyPwBgzUcGScnb85x6Bs5TeESJkRtgpGBFOhibjY_B2Z3fK-M_tWulpobphsoc7lcy2VbGwXR1yY1uv2mIVw0duCqdMDvH7T4e6nxa-a7z2ORUhZRtUzE302adzcOJUm-zFz56A1_vFy_wRLp8fnua3S2goYT2kCJfCGVPp0iAnHMHMWuI4R4RXlFGNLGeKau1KJgTFleZIa2pcPatqR2o6ATcH7mar17Y2tstRtXIT_VrFXgbl5f-k841chZ1kuJqVA3IC8AFgYkgpWvfbxUjuPcuDZzl4lnvPsqdfQqBy8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis</title><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><creator>Nagai, Toshihiro ; Sato, Masato ; Kobayashi, Miyuki ; Yokoyama, Munetaka ; Tani, Yoshiki ; Mochida, Joji</creator><creatorcontrib>Nagai, Toshihiro ; Sato, Masato ; Kobayashi, Miyuki ; Yokoyama, Munetaka ; Tani, Yoshiki ; Mochida, Joji</creatorcontrib><identifier>ISSN: 1478-6354</identifier><identifier>EISSN: 1478-6354</identifier><identifier>EISSN: 1478-6362</identifier><identifier>DOI: 10.1186/s13075-014-0427-y</identifier><identifier>PMID: 25230745</identifier><language>eng</language><publisher>London: BioMed Central</publisher><ispartof>Arthritis research & therapy, 2014-09, Vol.16 (5), Article 427</ispartof><rights>Nagai et al.; licensee BioMed Central Ltd. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c324y-30167fcc8b6c0f7f214ee2f550258343b0e54a3bbf6477318b50bb3cfd98df2d3</citedby><cites>FETCH-LOGICAL-c324y-30167fcc8b6c0f7f214ee2f550258343b0e54a3bbf6477318b50bb3cfd98df2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189677/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189677/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Nagai, Toshihiro</creatorcontrib><creatorcontrib>Sato, Masato</creatorcontrib><creatorcontrib>Kobayashi, Miyuki</creatorcontrib><creatorcontrib>Yokoyama, Munetaka</creatorcontrib><creatorcontrib>Tani, Yoshiki</creatorcontrib><creatorcontrib>Mochida, Joji</creatorcontrib><title>Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis</title><title>Arthritis research & therapy</title><issn>1478-6354</issn><issn>1478-6354</issn><issn>1478-6362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkMtKAzEUhoMotlYfwN08QKO5TqYbQUu9QMGNLlyFJJN0ItNJSdLK-PROrYjCgXPgP_-3-AC4xOgK46q8TpgiwSHCDCJGBOyPwBgzUcGScnb85x6Bs5TeESJkRtgpGBFOhibjY_B2Z3fK-M_tWulpobphsoc7lcy2VbGwXR1yY1uv2mIVw0duCqdMDvH7T4e6nxa-a7z2ORUhZRtUzE302adzcOJUm-zFz56A1_vFy_wRLp8fnua3S2goYT2kCJfCGVPp0iAnHMHMWuI4R4RXlFGNLGeKau1KJgTFleZIa2pcPatqR2o6ATcH7mar17Y2tstRtXIT_VrFXgbl5f-k841chZ1kuJqVA3IC8AFgYkgpWvfbxUjuPcuDZzl4lnvPsqdfQqBy8A</recordid><startdate>20140918</startdate><enddate>20140918</enddate><creator>Nagai, Toshihiro</creator><creator>Sato, Masato</creator><creator>Kobayashi, Miyuki</creator><creator>Yokoyama, Munetaka</creator><creator>Tani, Yoshiki</creator><creator>Mochida, Joji</creator><general>BioMed Central</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20140918</creationdate><title>Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis</title><author>Nagai, Toshihiro ; Sato, Masato ; Kobayashi, Miyuki ; Yokoyama, Munetaka ; Tani, Yoshiki ; Mochida, Joji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c324y-30167fcc8b6c0f7f214ee2f550258343b0e54a3bbf6477318b50bb3cfd98df2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nagai, Toshihiro</creatorcontrib><creatorcontrib>Sato, Masato</creatorcontrib><creatorcontrib>Kobayashi, Miyuki</creatorcontrib><creatorcontrib>Yokoyama, Munetaka</creatorcontrib><creatorcontrib>Tani, Yoshiki</creatorcontrib><creatorcontrib>Mochida, Joji</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Arthritis research & therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nagai, Toshihiro</au><au>Sato, Masato</au><au>Kobayashi, Miyuki</au><au>Yokoyama, Munetaka</au><au>Tani, Yoshiki</au><au>Mochida, Joji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis</atitle><jtitle>Arthritis research & therapy</jtitle><date>2014-09-18</date><risdate>2014</risdate><volume>16</volume><issue>5</issue><artnum>427</artnum><issn>1478-6354</issn><eissn>1478-6354</eissn><eissn>1478-6362</eissn><cop>London</cop><pub>BioMed Central</pub><pmid>25230745</pmid><doi>10.1186/s13075-014-0427-y</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1478-6354 |
ispartof | Arthritis research & therapy, 2014-09, Vol.16 (5), Article 427 |
issn | 1478-6354 1478-6354 1478-6362 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4189677 |
source | DOAJ Directory of Open Access Journals; SpringerLink Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central |
title | Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A50%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bevacizumab,%20an%20anti-vascular%20endothelial%20growth%20factor%20antibody,%20inhibits%20osteoarthritis&rft.jtitle=Arthritis%20research%20&%20therapy&rft.au=Nagai,%20Toshihiro&rft.date=2014-09-18&rft.volume=16&rft.issue=5&rft.artnum=427&rft.issn=1478-6354&rft.eissn=1478-6354&rft_id=info:doi/10.1186/s13075-014-0427-y&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4189677%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25230745&rfr_iscdi=true |